# First-in-Human Trial of DS1025a in Participants With Advanced Solid Tumors

> **NCT07681882** · PHASE1 · RECRUITING · sponsor: **Daiichi Sankyo** · enrollment: 45 (estimated)

## Conditions studied

- Advanced Solid Tumor
- Metastatic Solid Tumor
- Unresectable Solid Tumor

## Interventions

- **DRUG:** DS1025a

## Key facts

- **NCT ID:** NCT07681882
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-06
- **Primary completion:** 2028-01-21
- **Final completion:** 2029-01-21
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681882, "First-in-Human Trial of DS1025a in Participants With Advanced Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07681882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*